Pearsall Lab News

Lab accomplishments and announcements

July 6, 2026: Upcoming autumn 2026 conference and symposium abstracts

June 1 2026: Dr. Pearsall presents in Hollings Cancer Center Meeting

elizabeth pearsall retinal angiogenesis lab musc works at her bench

Dr. Pearsall was excited to present as a guest speaker for the Developmental Cancer Therapeutics (DCT) research program. DCT is part of Hollings Cancer Center, and is focused on identifying new mechanisms of disease and therapeutic targets.

She presented her sexual dimorphism work. However, in the context of this presentation, she used the work as an example of how multiple ocular angiogenesis models could be strategically combined to build a cursory physiologic landscape of an undefined phenomenon .

May 6, 2026: Dr. Nagingar presents in MIT section winners’ oral poster blitz

Dr. Atiyabanu Nagingar postdoctoral fellow for Dr. Pearsall's lab, presents sexual dimorphism in CNV ARVO 2026 MIT post blitz
Dr. Atiyabanu Nagingar postdoctoral fellow for Dr. Pearsall's lab, presents sexual dimorphism in CNV ARVO 2026 MIT post blitz

Dr. Nagingar proudly presents her data

Dr. Nagingar’s presentation in the poster blitz round was outstanding! Dr. Pearsall is thankful for the recognition and visibility this brings to her lab, especially as a junior PI, as is Storm Eye Institute.

Nagingar was nervous to present among the elite, and Pearsall offered advice that had served her well:

Everyone else is just as nervous. But when flustered, pause for short moment and look at your data. It is your art, and you are lucky to be presenting it here. Nothing will more reassuring and encouraging.

She did just that. And it worked.

May 5, 2026: Dr. Naginar named section winner in MIT poster session to advance as finalist

MIT finalists with Dr. Nagingar pictured back right

Dr. Nagingar successfully competed in the MIT poster session, placing first in the retinal cell biology section. She will now advance as a finalist to compete in an oral poster blitz session, where section winners will present a 3-minute, 2-slide rapid pitch of their work.

May 3, 2026: Pearsall lab posters presented in AMD Pathology I session

Dr. Pearsall’s senior-author posters were expertly presented by first authors Dr. Ford Gordon, a PGY-3 Storm Eye resident, and Pearsall Lab postdoctoral fellow Dr. Atiyabanu Nagingar:

  • Dr. Gordon: Statistical rigor of laser-induced CNV data analysis: should individual lesions be considered independent replicates?

  • Dr. Nagingar: Age-dependent sexual dimorphism in laser-induced CNV

March 10, 2026: Pearsall lab postdoc Dr. Atiyabanu Nagingar receives high honors for ARVO 2026

atiyabanu nagingar arvo 2026 mit  elizabeth pearsall musc storm eye institute

Congratulations to postdoctoral fellow Dr. Atiyabanu Nagingar, who was selected to compete in the prestigious Members-in-training (MIT) Outstanding Poster Competition at the ARVO 2026 Annual Meeting.

Forty elite competitors, including Dr. Nagingar, were selected from a pool of several thousand contenders. Additionally, Dr. Nagingar received a $750 Bright Focus Travel Grant‍.